Skip to content

Industries

Life Sciences

Sterility, potency and traceability are decided by the building as much as by the process inside it. Our management team has worked on 20+ EU-GMP / WHO-GMP compliant facilities across solid-dose, liquid and sterile production, medical device assembly, and hospital and laboratory clean zones.

Industries

Introduction

A life sciences facility needs a complete architecture: air handling, HEPA filtration and pressure cascades to EU GMP Grade A/B/C/D and ISO 14644-1; clean utilities — Purified Water, WFI and Pure Steam — and the process piping that carries them; and DQ/IQ/OQ/PQ qualification under GAMP 5, with data integrity to ALCOA+ and records that answer to 21 CFR Part 11 and Annex 11.

Overview

Facilities that protect the patient at the end of the process

Sterility, potency and traceability are decided by the building as much as by the process inside it. Everything we engineer for this sector answers to that.

A sterile manufacturing facility has to do three things at once: keep contamination away from open product, keep incompatible materials and people apart, and produce a record that shows it did both. The engineering that delivers this is unforgiving. A pressure cascade that collapses when a door opens, an airlock sequence that lets two flows meet, or a monitoring system whose audit trail can be edited will each stop a facility from being licensed, however well the rest of it performs.

The revised EU GMP Annex 1 made the Contamination Control Strategy the organizing document for all of it. Barrier technology, airflow patterns, personnel and material flows, cleaning and disinfection, utilities, monitoring and the qualification program have to hang together as one argument for why the process is protected. We engineer to that argument, and the design basis is written so it can be read alongside the strategy.

Our scope covers oral solid dose, liquids and semi-solids, sterile fill-finish, biotechnology and cell culture, high-potency and containment suites, medical device assembly, laboratories and hospital clinical environments. Each has a different governing risk — cross-contamination in OSD, aseptic integrity in fill-finish, containment and operator exposure in high-potency, particulate and ESD control in device assembly — and the design starts from that risk rather than from a template.

We also work in the ASEAN climate, and that changes how the plant is designed. Ambient conditions that sit near saturation for months make dehumidification a primary design problem rather than a trim function. Sizing for the peak dew-point design condition, staging dehumidification correctly and controlling the reheat penalty are what keep a Grade B suite inside its humidity band in August without the energy bill of a plant that was designed for a temperate climate.

Capabilities

Scope of work

Turnkey EU-GMP / WHO-GMP facilities for pharmaceutical, biotech, medical device, and healthcare production — engineered for sterility assurance, data integrity (ALCOA+), and seamless regulatory compliance.

Pharmaceutical & Biotech Manufacturing

Our management team has worked on 20+ EU-GMP / WHO-GMP compliant facilities. Our expertise spans oral solid dose (OSD), liquid, and sterile manufacturing, featuring advanced pressure cascades, strict cleanroom zoning (Grade A/B/C/D), high-OEB containment for oncology, and precise temperature controls for bioprocessing and viral vectors.

Medical Device Assembly

We engineer precision-controlled environments optimized for medical device manufacturing. Our designs incorporate rigorous particulate control, ESD protection, and risk-based cleanroom classifications compliant with international ISO standards, ensuring safe assembly and packaging.

Hospitals, Labs & Sterile Clinical Zones

Patient safety relies on engineered clean air. We design and install critical HVAC systems for operating rooms, protective isolation rooms, and compounding pharmacies. Furthermore, we design specialized laboratory ventilation for fume hoods, biological safety cabinets, and analytical instrument zones.

Cleanroom HVAC & Contamination Control

The cleanroom is the heart of every GMP facility. We engineer complete HVAC architecture — air handling, HEPA/ULPA filtration, pressure cascades, and cross-contamination control — classified to ISO 14644 and EU GMP Grade A/B/C/D and validated to hold critical conditions in any climate, including high-humidity tropical environments.

Clean Utilities & Process Piping

Sterile production depends on pharmaceutical-grade utilities. We design and install clean utility systems — Purified Water (PW), Water for Injection (WFI), and Pure Steam — alongside orbital-welded process piping, all documented and traceable to support qualification and routine GMP operation.

Validation, Qualification & GMP Compliance

Compliance is engineered in, not bolted on. Operating under GAMP 5, we deliver complete DQ / IQ / OQ / PQ validation packages with full traceability, plus SCADA / EBR validation to 21 CFR Part 11 and EU-GMP Annex 11.

Our approach

How a life sciences facility is engineered

The sequence that takes a process description to a licensed, qualified facility.

  1. Process definition and containment assessment

    Product, process steps, batch size, campaign pattern, open-product operations and cleaning regime are defined, and the containment requirement is assessed against occupational exposure limits and cross-contamination risk. This is what determines grade, barrier technology and whether the facility can be multi-product.

    Output

    • Process flow and open-product assessment
    • Containment and OEB assessment
    • Cross-contamination risk assessment
  2. Zoning, flows and the contamination control basis

    Rooms are graded, the pressure cascade is set, and personnel, material, product, waste and equipment flows are laid out so incompatible movements never cross. Airlock strategy, gowning sequence, pass-through provision and waste egress are designed together — these are the decisions the Contamination Control Strategy will later have to defend.

    Output

    • Room grade and pressure cascade layout
    • Personnel, material and waste flow diagrams
    • Airlock and gowning strategy
  3. HVAC, barrier and utility design

    Air handling architecture is set — recirculation and once-through boundaries, unidirectional zones, terminal filtration and the segregation needed for containment. Barrier technology is selected where the process demands it, and clean utilities are designed with the sanitization regime, sampling points and drainability built in rather than added later.

    Output

    • HVAC schematics and airflow schedules
    • Barrier and containment specification
    • Clean utility P&IDs and sanitization strategy
  4. Automation, monitoring and data integrity

    The monitoring and control architecture is specified for what the record has to prove: continuous monitoring of critical parameters, alarm and excursion handling, secure and attributable audit trail, user access control and electronic signature. Software is categorized under GAMP 5 and specified so verification is possible.

    Output

    • Control philosophy and functional specification
    • Monitoring points and alarm limit schedule
    • Data integrity and Part 11 / Annex 11 assessment
  5. Construction, commissioning and qualification

    Installation is inspected against hold points, systems are commissioned and balanced, and IQ, OQ and PQ are executed against protocols agreed with your quality unit. Cleanroom classification, filter integrity, recovery, airflow visualization and containment performance are all verified before the facility is released.

    Output

    • Commissioning and balancing records
    • IQ, OQ and PQ packages
    • Classification, integrity and recovery test results
  6. Handover and ongoing compliance

    The facility is handed over with a complete, indexed documentation set and a maintenance and requalification program that keeps it in its validated state. Periodic retesting, calibration and change control continue under a service agreement so the position at the next inspection is known rather than hoped for.

    Output

    • Qualification and handover package
    • Maintenance and requalification program
    • Training and operating documentation

Technical parameters

Environmental and utility criteria

Published limits and guidance values from the standards named, alongside typical design values where indicated. Project criteria are set in the design basis and in your Contamination Control Strategy.

Cleanroom grades — EU GMP Annex 1 and ISO 14644-1

Grade A — critical open-product zoneISO 5 at rest and in operation; ≤ 3,520 particles ≥ 0.5 µm per m³
Grade B — background to Grade AISO 5 at rest, ISO 7 in operation
Grade C — preparation and less critical stepsISO 7 at rest, ISO 8 in operation
Grade D — support and material handlingISO 8 at rest
Grade A airflow velocity0.36 – 0.54 m/s at the working position
Pressure cascade10 – 15 Pa between adjacent grades, with direction fixed by the containment strategy
RecoveryDesign target ≤ 20 minutes to classified condition after disturbance

Air, temperature and humidity

Air change rate, Grade B and CTypically 20 – 60 ACPH, from calculated load and recovery requirement
Terminal filtrationHEPA H14 ≥ 99.995 % at MPPS for Grade A and B; H13 or H14 elsewhere by risk
TemperatureTypically 20 ± 2 °C; gowning-driven set points in Grade B suites
Relative humidityTypically 45 ± 10 % RH; tighter bands for hygroscopic and moisture-sensitive product
Containment suitesOnce-through or safe-change recirculation, negative cascade, bag-in/bag-out filtration
Barrier technologyRABS and isolator integration where the process requires separation from the operator

Clean utilities

Purified WaterConductivity ≤ 1.3 µS/cm at 25 °C (USP <645> Stage 1, tighter than the Ph. Eur. limit) and TOC ≤ 500 ppb, meeting both Ph. Eur. and USP
Water for InjectionPh. Eur. and USP limits, hot- or cold-loop distribution with defined sanitization
Pure steamCondensate to WFI limits; non-condensable gas, dryness and superheat to EN 285
Distribution316L, orbital welded, drainable, dead-leg and slope limits fixed at design
Process gasesCompressed air and nitrogen classified to ISO 8573-1 with point-of-use filtration

Monitoring, automation and records

Continuous monitoringParticle count, differential pressure, temperature and humidity at critical locations
Environmental monitoring supportViable and non-viable sampling locations set from a documented risk assessment
Electronic records21 CFR Part 11 and EU GMP Annex 11 — access control, audit trail, electronic signature
Data integrityALCOA+ principles applied to the design, retention and review of records
Software lifecycleGAMP 5 categorization, specification, verification and traceability
QualificationDQ, IQ, OQ and PQ to EU GMP Annex 15, with requalification interval defined at handover

Deliverables

What a life sciences project delivers

  • User Requirement Specification and design basis
  • Containment and cross-contamination risk assessment
  • Room grade schedule, pressure cascade and room data sheets
  • Personnel, material, product and waste flow diagrams
  • HVAC schematics, airflow schedules and psychrometric calculations
  • Clean utility P&IDs, sanitization strategy and sampling schedule
  • Barrier, isolator and containment specification where applicable
  • Control philosophy, monitoring schedule and alarm limits
  • Data integrity and Part 11 / Annex 11 assessment
  • Federated BIM model and issued-for-construction drawings
  • DQ, IQ, OQ and PQ protocols and executed reports
  • Classification, filter integrity, recovery and airflow visualization results
  • Maintenance, requalification and calibration program
  • Indexed handover and qualification documentation package

Compliance

Regulatory framework

EU GMP Annex 1Manufacture of sterile medicinal products
Contamination Control Strategy, grades, barrier technology, monitoring and airflow visualization.
EU GMP Annex 15Qualification and validation
DQ, IQ, OQ, PQ, periodic review and requalification.
EU GMP Annex 11 · 21 CFR Part 11Computerised systems and electronic records
Audit trail, access control, electronic signature and record retention.
21 CFR 210 · 211US cGMP for finished pharmaceuticals
Applied where product is destined for the United States market.
WHO TRS · PIC/S PE 009GMP guidance
Applied for WHO-prequalified supply and inspection by PIC/S member authorities.
ISO 14644Cleanrooms and controlled environments
Classification, monitoring, test methods, design and construction.
ISO 13485 · ISO 14644-7Medical devices and separative devices
Quality system context for device assembly and isolator or RABS installations.
GAMP 5 · ALCOA+Computerized systems and data integrity
Software categorization, verification strategy and record integrity principles.

Talk to our engineers

Tell us about your facility and we will route your inquiry to the right engineering lead.

Insights

Technical notes from this practice

View all insights (379)

Technical resources

Free references for this work

The references we reach for ourselves. No sign-up, and where a figure comes from a standard, we name it.

Questions

Life Sciences — questions we are asked

Answered by the engineers who do the work.

It makes the Contamination Control Strategy the document everything else has to be consistent with, and raises expectations around barrier technology, airflow visualization, and the justification for monitoring locations. In practice it means design decisions need a written, risk-based rationale rather than precedent — and that the strategy, the design basis and the qualification program all have to tell the same story.

It depends on the products. Multi-product operation is engineered through segregation, containment, dedicated or cleanable equipment and validated cleaning, and the decision rests on a toxicological assessment and a cross-contamination risk assessment. Some products — certain highly sensitizing or high-potency compounds — require dedicated facilities, and the assessment is where that is established, before the layout is fixed.

Both separate the operator from open product. A RABS uses a rigid enclosure with unidirectional airflow and controlled access within a Grade B background. An isolator is sealed, held at a defined pressure regime with its own air handling, and is bio-decontaminated, which allows a lower-grade background. The isolator gives higher assurance and lower background running cost; the RABS gives more operational flexibility and a lower capital cost. The process, batch pattern and intervention frequency decide which is appropriate.

By sizing for the peak dew-point design condition rather than the peak dry-bulb, and by staging dehumidification so the load is removed at the most efficient point instead of over-cooling and reheating everything. Depending on the band required, that means correctly sized cooling coil dehumidification, desiccant support, or both — with heat recovery to limit the reheat penalty. Bands down to ± 2 % RH are achievable where the process needs them.

That the record generated by the facility is attributable, legible, contemporaneous, original and accurate, and remains so. In design terms: secure user access with individual accounts, an audit trail that cannot be altered, time synchronization across systems, defined data retention and backup, controlled configuration changes, and monitoring specified so critical parameters are recorded continuously rather than sampled by hand.

Yes. Work in a live facility is planned around the requalification boundary — temporary containment, agreed shutdown windows, controlled access routes, and an impact assessment covering every adjacent classified area. The surrounding plant stays in its validated state throughout, and the affected systems are requalified against protocols agreed in advance.

We provide the engineering and qualification evidence, and support your quality team with technical explanation of the design rationale, the qualification results and the maintenance record. The documentation is structured so a design decision can be traced from the requirement through to the test that verified it.